SCHEMBL4849200

SCHEMBL4849200

Cc1cccc(-c2ccc(OCCN(C)C)c(C=O)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.47
ALDH1A1 P00352 4/20 0.47
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
SLC6A9 P48067 2/20 0.44
HTR7 P34969 1/20 0.43
ESR1 P03372 2/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
ESR2 Q92731 1/20 0.41
HTR1B P28222 1/20 0.40
KDR P35968 2/20 0.40
KIT P10721 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849949 0.89 ADRB2 (0.45) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4852503 0.88 ALDH1A1 (0.60) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4853715 0.88 ALDH1A1 (0.60) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4849767 0.88 KDM4E (0.47) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4846536 0.84 CYP1A2 (0.53) KDM4EALDH1A1MAPTADRB2ADRB1
SCHEMBL4854088 0.82 KDM4E (0.45) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4853655 0.81 ERN1 (0.53) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4848018 0.81 ADRB2 (0.45) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4854690 0.81 ADRB2 (0.45) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL4845580 0.81 SLC6A9 (0.49) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed